The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

How is Matinas BioPharma Taking Rare Omega-3 Fatty Acids to the Next Level: Developing Products Beyond Fish Oil Extracts

In today's SNN Q&A, Robert Kraft had the opportunity to speak with Roelof Rongen, President and CEO of Matinas BioPharma Inc. (OTCQB: MTNB) to discuss fatty acids, the science behind fatty acids, and how they are developing pharmaceuticals that go beyond the more well-known fish oil extracts.

Share With

Monday, October 20, 2014

   

© 2017 Stock News Now